SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001315863-20-000507
Filing Date
2020-05-29
Accepted
2020-05-29 11:20:11
Documents
1
Effectiveness Date
2020-05-29
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 5647
  Complete submission text file 0001315863-20-000507.txt   6929
Mailing Address CO BIOPHARMA CREDIT INVESTMENTS V GP LLC CAYMAN CORPORATE CENTRE, 27 HOSPITAL ROA GEORGE TOWN E9 KY1-9008
Business Address CO BIOPHARMA CREDIT INVESTMENTS V GP LLC CAYMAN CORPORATE CENTRE, 27 HOSPITAL ROA GEORGE TOWN E9 KY1-9008 212-883-2296
BioPharma Credit Investments V LP (Filer) CIK: 0001771639 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-342013 | Film No.: 20925153